ReviewFrontiers in oncology2015

Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer.

Huifeng Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.